Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Drug Injury Lawsuits: List of Some Cases Filed in First Half of 2021

August 9, 2021 By Law Offices of Thomas J. Lamb, P.A.

A drug injury lawsuit is a personal injury case or a wrongful death case involving a serious drug side effect or a severe adverse drug reaction. Here are some of the prescription medications for which drug injury lawsuits were filed against the responsible pharmaceutical company in the first half of 2021: Xeljanz Beovu Elmiron … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Actemra, Belviq, Beovu, Elmiron, Farxiga, Injectafer, Invokana, Jardiance, Ocaliva, Tasigna, Uloric

There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020

April 13, 2021 By Law Offices of Thomas J. Lamb, P.A.

There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020. This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, Colorectal Cancer, lung cancer, Pancreatic Cancer, Rectal cancer

Some Information About Our Monthly Law Firm Newsletter

March 8, 2021 By Law Offices of Thomas J. Lamb, P.A.

The Lamb Law Office Newsletter is a monthly communication from our law firm to help keep you up to date with some of the cases that we are working on for clients at the present time. In addition, we provide at least one information resource item per month, which you or someone you know might find helpful from time to time. Past … [Read more...]

Filed Under: Uncategorized Tagged With: Asbestos Mesothelioma, Belviq, benzene, Beovu, breast implants, Elmiron, genx, Injectafer, Lamb Law Office Newsletter, Law Firm Newsletter, Monthly Newsletter, Newsletter, sglt2 inhibitors, Xeljanz

FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks

September 22, 2020 By Law Offices of Thomas J. Lamb, P.A.

In this FDA staff article, “Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial”, which was published by the New England Journal of Medicine (NEJM), the early 2020 FDA Belviq recall decision was explained. Essentially, this FDA action after a careful analysis of Belviq safety data that revealed excess … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, leukemia, lung cancer, Pancreatic Cancer, Rectal cancer

After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer

May 21, 2020 By Law Offices of Thomas J. Lamb, P.A.

Following the Belviq recall in February 2020 some of those patients on Belviq developing cancer filed Belviq lawsuits alleging a failure to warn about the risk of cancer associated with Belviq. We are investigating possible Belviq lawsuits that involve patients on Belviq developing cancer. At the present time, our focus for these Belviq lawsuits … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, lung cancer, Pancreatic Cancer, Rectal cancer

Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung

February 18, 2020 By Law Offices of Thomas J. Lamb, P.A.

The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, and noted that … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, lung cancer, Pancreatic Cancer, Rectal cancer

Weight-Loss Medicine Belviq Increased Risk Of Cancers Says FDA Drug Safety Communication

January 16, 2020 By Law Offices of Thomas J. Lamb, P.A.

UPDATE:  "FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market"  (2-13-2020 FDA Drug Safety Communication) "Potential risk of cancer outweighs the benefits" Imbalances in specific cancers including pancreatic, colorectal, and lung contributed to the observed overall imbalance in cancer … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.